EverPoint Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

EverPoint Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,500,000	Closed	-$9.07M	–	507
2016 Q1	$9.07M	Sell	1,500,000 -400,000	-21%	-$2.4M	0.18%	147
2015 Q4	$17.3M	Buy	1,900,000 +850,000	+81%	+$6.55M	0.36%	79
2015 Q3	$5.92M	Buy	+1,050,000	New	+$8.66M	0.15%	193
2015 Q2	–	Sell	-950,000	Closed	-$14.9M	–	567
2015 Q1	$14.9M	Sell	950,000 -150,000	-14%	-$2.32M	0.28%	112
2014 Q4	$16.7M	Buy	1,100,000 +300,000	+38%	+$3.64M	0.38%	88
2014 Q3	$8.63M	Buy	800,000 +175,000	+28%	+$2.29M	0.2%	166
2014 Q2	$9.54M	Buy	+625,000	New	+$8.99M	0.2%	154

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

EverPoint Asset Management's SGMO Position: Q2 2016 in Review

EverPoint Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2016, closing a stake of 1,500,000 shares — an estimated $9.07M sold.

EverPoint Asset Management first reported a position in SGMO in Q2 2014 and held it in 7 quarters. The position peaked at $17.3M in Q4 2015. 136 funds tracked by Wall St. Rank hold SGMO as of Q2 2016.

EverPoint Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
EverPoint Asset Management sold 1,500,000 SANGAMO THERAPEUTICS INC shares in Q2 2016, an estimated $9.07M.
EverPoint Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 7 quarters.
EverPoint Asset Management's SANGAMO THERAPEUTICS INC position peaked at $17.3M in Q4 2015.
136 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2016.

Based on EverPoint Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.